Anuradha Dube

Employment

• Central Drug Research Institute INSA Senior Scientist
  2016 - Present

Education

• Central Drug Research Institute Ph.D
  1978 - Present

Projects & Funding

Projects & funding information is unavailable.

Publications (154)

• A Chimera of Th1 Stimulatory Proteins of Leishmania donovani Offers Moderate Immunotherapeutic Efficacy with a Th1‐Inclined Immune Response against Visceral Leishmaniasis
  BioMed Research International 2021 DOI: 10.1155/2021/8845826
  +Save
• Status of IL-4 and IL-10 driven markers in experimental models of Visceral Leishmaniasis
  Parasite Immunology 2021 DOI: 10.1111/pim.12783
  +Save
• Purified Splenic amastigotes of Leishmania donovani‐Immunoproteomic approach for exploring Th1 stimulatory polyproteins
  Parasite Immunology 2020 DOI: 10.1111/pim.12729
  +Save
• Comparison Between Immuno-Clinicopathological Features of Experimental and Human Visceral Leishmaniasis by Leishmania donovani
  Acta Parasitologica 2020 DOI: 10.2478/s11686-019-00127-8
  +Save
• Parasitic load determination by differential expressions of 5-lipoxygenase and PGE2 synthases in visceral leishmaniasis
  Prostaglandins and Other Lipid Mediators 2020 DOI: 10.1016/j.prostaglandins.2019.106390
  +Save
• Preventive as well as therapeutic significances of linoleic acid in the containment of Leishmania donovani infection
  Biochimie 2020 DOI: 10.1016/j.biochi.2020.04.024
  +Save
• Visceral leishmaniasis: An overview of vaccine adjuvants and their applications
  Vaccine 2019 DOI: 10.1016/j.vaccine.2019.04.092
  +Save
• Immunogenicity and Protective Efficacy of T-Cell Epitopes Derived From Potential Th1 Stimulatory Proteins of Leishmania (Leishmania) donovani.
  Frontiers in immunology 2019 DOI: 10.3389/fimmu.2019.00288
  +Save
• Prophylactic interferon-γ and interleukin-17 facilitate parasite clearance in experimental visceral leishmaniasis
  Tropical Parasitology 2019 DOI: 10.4103/tp.TP_32_18
  +Save
• Protein quality control machinery in intracellular protozoan parasites: hopes and challenges for therapeutic targeting
  Cell Stress and Chaperones 2019 DOI: 10.1007/s12192-019-01016-9
  +Save